Healthcare,
Journal Year:
2020,
Volume and Issue:
8(3), P. 191 - 191
Published: June 29, 2020
The
obesity
epidemic
in
the
United
States
has
been
well
documented
and
serves
as
basis
for
a
number
of
health
interventions
across
nation.
However,
those
who
have
served
U.S.
military
(Veteran
population)
suffer
from
higher
numbers
an
overall
disproportionate
poorer
status
when
compared
to
older
non-Veteran
population
which
may
further
compound
their
risk.
This
study
examined
both
commonalities
differences
rates
associated
co-morbidities
among
Veteran
population,
utilizing
data
2018
Behavioral
Risk
Factor
Surveillance
System
(BRFSS).
These
are
considered
by
Centers
Disease
Control
Prevention
(CDC)
be
nation's
best
source
health-related
survey
data,
version
includes
437,467
observations.
Study
findings
show
not
only
significantly
risk
but
also
level
(higher
odds
ratio)
non-Veterans,
including
coronary
heart
disease
(CHD)
or
angina
(odds
ratio
(OR)
=
2.63);
stroke
(OR
1.86);
skin
cancer
2.18);
other
cancers
1.73);
chronic
obstructive
pulmonary
(COPD)
1.52),
emphysema,
bronchitis;
arthritis
rheumatoid
arthritis,
gout,
lupus,
fibromyalgia;
depressive
disorders
0.84),
diabetes
1.61)
at
0.95
confidence
interval
level.
The Lancet Healthy Longevity,
Journal Year:
2024,
Volume and Issue:
5(4), P. e287 - e296
Published: March 4, 2024
Multimorbidity
(multiple
conditions)
and
polypharmacy
medications)
are
increasingly
common,
yet
there
is
a
need
to
better
understand
the
prevalence
of
co-occurrence.
In
this
systematic
review,
we
examined
multimorbidity
among
adults
(≥18
years)
older
(≥65
in
clinical
community
settings.
Six
electronic
databases
were
searched,
87
studies
retained
after
two
levels
screening.
Most
focused
on
65
years
done
population-based
Although
operational
definitions
varied
across
studies,
consistent
cut-points
(two
or
more
conditions
five
used
most
studies.
adult
samples,
ranged
from
4·8%
93·1%,
while
2·6%
86·6%.
High
heterogeneity
between
indicates
for
reporting
specific
lists
medications
definitions.
Neuropsychiatric Disease and Treatment,
Journal Year:
2022,
Volume and Issue:
Volume 18, P. 375 - 389
Published: Feb. 1, 2022
Abstract:
Depression,
one
of
the
most
common
comorbidities
with
osteoarthritis
(OA),
affects
patient
prognosis
and
quality
life.
It
also
increases
overall
burden
disease.
This
subgroup
patients
has
not
been
effectively
managed
in
clinical
settings.
The
study
aimed
to
direct
physicians'
attention
co-occurrence
depression
OA.
Therefore,
this
review
summarizes
relevant
literature
published
over
past
10
years.
focus
is
on
prevalence
risk
factors
for
OA,
effects
OA
development
treatment
response,
comorbidity
mechanisms,
screening,
non-pharmacological
treatment.
research
etiology
driven
largely
by
epidemiological
studies.
Recent
studies
have
shown
that
high
levels
pain,
poor
function,
numbers
sites,
slow
gait
might
be
associated
depression.
However,
pathophysiology
remains
unclear.
In
addition
immune
inflammation
structural
changes
brain,
which
documented
brain
imaging
studies,
psychosocial
may
play
a
role.
evidence
indicates
can
treated
early
intervention;
however,
adjustments
need
made
individuals
comorbid
recommended
health
care
providers
pay
more
depressive
symptoms
Clinicians
should
develop
implement
an
individualized
comprehensive
plan
based
mental
assessment
teams
other
professionals
optimize
outcomes.
Keywords:
osteoarthritis,
depression,
epidemiology,
prognosis,
A
Letter
Editor
article.
International Journal of Mental Health Nursing,
Journal Year:
2025,
Volume and Issue:
34(1)
Published: Jan. 16, 2025
ABSTRACT
China
is
the
country
with
largest
population
of
older
persons.
Depression
most
common
mental
health
issue
among
adults,
a
trend
expected
to
increase
as
societies
continue
age.
With
global
in
depression
and
depressive
symptoms
this
demographic,
resulting
disease
burden
poses
significant
challenge
social
care
systems
China.
To
map,
summarise
examine
empirical
literature
on
prevalence
factors
associated
Chinese
an
integrative
review
was
conducted
informed
by
guidelines
Whittemore
Knafl.
The
search
encompassed
EMBASE,
SCOPUS,
CINAHL,
Web
Science,
PubMed,
PsycINFO,
SocINDEX,
National
Knowledge
Infrastructure
Database
Wanfang
Database.
included
65
studies,
29
English
36
Chinese.
reported
or
adults
3.78%–84.3%.
Based
biopsychosocial
model,
were
clustered
follows:
biological
(physical
health,
disability,
drug
effects,
gender,
age,
diets,
physical
activities),
psychological
(self‐esteem,
coping
skills,
trauma,
emotions,
beliefs,
hobbies,
lifestyle)
(family
relationships,
peers,
family
circumstances,
school,
residential
areas,
support,
structure).
This
synthesised
research
China,
highlighting
varying
across
diverse
geographical
locations.
Given
high
certain
cohorts,
early
identification
assessment
essential
reducing
burden.
use
model
provided
theoretical
lens
holistic
way.
Thus,
furthering
understanding
that
require
close
consideration
future
practice
innovations
Australian & New Zealand Journal of Psychiatry,
Journal Year:
2020,
Volume and Issue:
54(12), P. 1200 - 1211
Published: Aug. 3, 2020
Objective:
Mental
health
disorders
are
a
major
concern
in
older
people
and
associated
with
higher
risk
of
disability,
frailty
early
mortality.
This
study
aimed
to
conduct
contemporary
population-based
assessment
the
prevalence,
trends
factors
mental
individuals
who
living
permanent
residential
aged
care
(PRAC)
Australia.
Methods:
A
retrospective
cross-sectional
was
conducted
using
national
data
from
Registry
Senior
Australians,
cohort
Australians
had
eligibility
entered
PRAC
between
2008
2016.
Stepwise
multivariate
logistic
regression
modeling
applied
identify
disorders.
Results:
Of
430,862
included
this
study,
57.8%
at
least
one
disorder.
The
prevalence
depression,
phobia/anxiety
psychosis
were
as
follows:
46.2%
(95%
confidence
interval
=
[46.0%,
46.3%]),
14.9%
[14.8%,
15.0%])
9.7%
[9.6%,
9.8%]),
respectively.
likelihood
having
disorder
for
those
(adjusted
odds
ratio
[95%
interval])
relatively
younger,
specifically
every
10-year
increment
age,
44.0%
lower
(0.56,
[0.55,
0.56]);
female
(1.33
[1.32,
1.35]);
increasing
numbers
physical
comorbidities,
6–10
(1.26
[1.24,
1.29])
or
11–15
(1.48
[1.45,
1.51])
more
than
15
(1.64
[1.58,
1.71])
compared
less
five
comorbidities;
limitations
related
tasks
(1.05
[1.04,
1.07]),
meals
(1.04
[1.02,
1.05])
social
community
participation
(1.10
[1.08,
1.12]).
Conclusion:
burden
high
these
conditions
tend
be
several
comorbidities
and/or
functional
limitations.
Understanding
profile
entry
into
can
used
evidence
baseline
resource
allocation
population
evaluation
future
needs
services.
Frontiers in Public Health,
Journal Year:
2021,
Volume and Issue:
9
Published: Aug. 9, 2021
Coronavirus
disease
2019
(COVID-19),
a
respiratory
of
unknown
origin,
has
high
rate
morbidity
and
mortality.
Individuals
with
mental
disorders
may
have
higher
risk
infection
worse
clinical
outcomes
because
variety
factors
such
as
poorer
general
resilience
lower
immune
function.
However,
there
been
no
studies
to
date
specifically
investigating
the
COVID-19
associated
mortality
in
these
patients.
This
was
addressed
present
study
by
analyzing
data
473,958
subjects
included
UK
Biobank,
14,877
whom
tested
positive
for
infection.
Logistic
regression
analysis
performed
evaluate
associations
between
risks
The
results
showed
that
who
were
diagnosed
disorder
had
significantly
developing
outcome
evidenced
rates
COVID-19-related
mortality,
strongest
effects
observed
dementia.
Among
dementia
subtypes,
Alzheimer
patients
highest
(7.39-fold
increase)
(2.13-fold
increase).
Late-life
anxiety
only
increased
while
late-life
depression
not
but
also
outcome.
These
findings
highlight
need
prioritize
disorders-especially
those
experience
later
life-when
implementing
preventive
strategies
vaccinations.
Journal of Pharmacy Practice and Research,
Journal Year:
2021,
Volume and Issue:
51(4), P. 280 - 299
Published: July 20, 2021
Abstract
Aims
Polypharmacy
is
associated
with
multiple
adverse
health
outcomes.
The
objective
of
this
systematic
review
and
meta‐analysis
was
to
explore
the
association
between
polypharmacy
depression.
Methods
results
A
literature
conducted
by
searching
MEDLINE,
Scopus,
Science
Direct,
CINAHL
Complete
identify
studies
assessing
depression
published
until
November
2020.
performed
using
random
effect
models.
Heterogeneity
assessed
I
2
‐statistic.
Nineteen
were
included
in
meta‐analysis.
We
found
that
an
increase
number
drugs
increased
risk
(OR
=
1.55
[95%
CI:
1.01,
2.36;
62%,
n
2]).
Further,
defined
as
concurrent
use
five
or
more
medications
1.73
1.39,
2.14],
83%,
8).
Conclusion
This
revealed
polypharmacy,
both
discretely
categorically
defined,
International Journal of Environmental Research and Public Health,
Journal Year:
2023,
Volume and Issue:
20(3), P. 2615 - 2615
Published: Feb. 1, 2023
Multimorbidity
has
been
associated
with
adverse
health
outcomes,
such
as
reduced
physical
function,
poor
quality-of-life
(QoL),
self-rated
health.The
association
between
quality
of
life,
social
support,
sense
loneliness
and
sex
age
in
older
adult
patients
affected
by
two
or
more
chronic
diseases
(multimorbidity)
was
evaluated.Patients
n.
162
multimorbidity
living
family
members.MMSE-Mini-Mental-State-Examination;
ADL-Activities
Daily
Living;
Social
Schedule:
demographic
variables;
Loneliness
Scale
-de
Jong
Gierveld;
Quality-of-Life-FACT-G;
WHOQOL-BRIEF
relationships.Multivariate
Regression
Analysis.The
three
have
worse
dimensions
FACT-G
total
score
(p
=
0.029),
QoL
Physical-well-being
0.003),
well-being
Emotional-well-being
0.012),
Functional-well-being
<
0.001),
than
those
two.
Multiple
linear
regression
QoL:
FACT_G
score,
PWB,
SWB,
EWB,
FWB
dependent
variables.
In
the
presence
an
increase
patient's
(B
-0.004,
p
0.482),
PWB
-0.024,
0.014),
SWB
-0.022,
0.051),
EWB
-0.001,
0.939),
-0.023,
0.013)
decrease
average
0.1,
solitude
increases
-0.285,
0.000),
-0.435,
SWB(B
-0.401,
EWB(B
-0.494,
FWB(B
-0.429,
0.000)
0.4.A
advancing
are
bad
quality-of
life
self-sufficient
elderly
multimorbidity.Demonstrating
that
loneliness,
well
interpersonal
relations,
is
predictive
helps
identify
people
most
at
risk
for
common
symptoms
lays
groundwork
research
concerning
both
diagnosis
treatment.